Vaughan Nelson Investment Management L.P. boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 768,940 shares of the company's stock after purchasing an additional 35,435 shares during the period. Vaughan Nelson Investment Management L.P. owned approximately 0.83% of Acadia Healthcare worth $48,758,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in ACHC. Blue Trust Inc. lifted its stake in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock valued at $36,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC lifted its stake in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Acadia Healthcare in the 2nd quarter valued at approximately $59,000. Covestor Ltd boosted its stake in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock worth $72,000 after purchasing an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare in the 3rd quarter worth approximately $86,000.
Analysts Set New Price Targets
A number of research firms recently commented on ACHC. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Barclays decreased their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a research note on Monday, September 30th. KeyCorp assumed coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $86.67.
Get Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Stock Down 3.9 %
ACHC traded down $1.54 during trading hours on Friday, hitting $37.82. 1,846,000 shares of the company's stock were exchanged, compared to its average volume of 1,941,511. Acadia Healthcare Company, Inc. has a 1-year low of $37.78 and a 1-year high of $87.77. The stock's 50-day moving average is $58.05 and its two-hundred day moving average is $65.60. The stock has a market cap of $3.51 billion, a price-to-earnings ratio of 12.40, a PEG ratio of 1.68 and a beta of 1.33. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to analysts' expectations of $819.42 million. During the same quarter in the prior year, the company posted $0.91 earnings per share. The firm's revenue was up 8.7% on a year-over-year basis. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.